Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Pretreatment nutritional status is an important prognostic factor in patients treated with conventional cytotoxic chemotherapy. In the era of target therapies, its value is overlooked and has not been investigated. The aim of our study is to evaluate the value of nutritional status in targeted therapy. Methods: A total of 2012 patients with non-small cell lung cancer (NSCLC) were reviewed and 630 patients with activating epidermal growth factor receptor (EGFR) mutation treated with EGFR tyrosine kinase inhibitor (TKI) were enrolled for the final analysis. Anemia, body mass index (BMI), and prognostic nutritional index (PNI) were considered as nutritional factors. Hazard ratio (HR), progression-free survival (PFS) and overall survival (OS) for each group were calculated by Cox proportional analysis. In addition, scores were applied for each category and the sum of scores was used for survival analysis. Results: In univariable analysis, anemia (HR, 1.29; p = 0.015), BMI lower than 18.5 (HR, 1.98; p = 0.002), and PNI lower than 45 (HR, 1.57; p < 0.001) were poor prognostic factors for PFS. Among them, BMI and PNI were independent in multi-variable analysis. All of these were also significant prognostic values for OS. The higher the sum of scores, the poorer PFS and OS were observed. Conclusions: Pretreatment nutritional status is a prognostic marker in NSCLC patients treated with EGFR TKI. Hence, baseline nutritional status should be more carefully evaluated and adequate nutrition should be supplied to these patients.
Abstract
Background/Aims: Pretreatment nutritional status is an important prognostic factor in patients treated with conventional cytotoxic chemotherapy. In the era of target therapies, its value is overlooked and has not been investigated. The aim of our study is to evaluate the value of nutritional status in targeted therapy. Methods: A total of 2012 patients with non-small cell lung cancer (NSCLC) were reviewed and 630 patients with activating epidermal growth factor receptor (EGFR) mutation treated with EGFR tyrosine kinase inhibitor (TKI) were enrolled for the final analysis. Anemia, body mass index (BMI), and prognostic nutritional index (PNI) were considered as nutritional factors. Hazard ratio (HR), progression-free survival (PFS) and overall survival (OS) for each group were calculated by Cox proportional analysis. In addition, scores were applied for each category and the sum of scores was used for survival analysis. Results: In univariable analysis, anemia (HR, 1.29; p = 0.015), BMI lower than 18.5 (HR, 1.98; p = 0.002), and PNI lower than 45 (HR, 1.57; p < 0.001) were poor prognostic factors for PFS. Among them, BMI and PNI were independent in multi-variable analysis. All of these were also significant prognostic values for OS. The higher the sum of scores, the poorer PFS and OS were observed. Conclusions: Pretreatment nutritional status is a prognostic marker in NSCLC patients treated with EGFR TKI. Hence, baseline nutritional status should be more carefully evaluated and adequate nutrition should be supplied to these patients.
참고문헌 (31)
- Argiles JM, "Cancer cachexia: understanding the molecular basis", Nat Rev Cancer, 14, pp.754~762 (2014)
- Lieffers JR, "A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands", Am J Clin Nutr, 89, pp.1173~1179 (2009)
- Ottery FD, "Cancer cachexia: prevention, early diagnosis, and management", Cancer Pract, 2, pp.123~131 (1994)
- Paccagnella A, "Nutritional intervention for improving treatment tolerance in cancer patients", Curr Opin Oncol, 23, pp.322~330 (2011)
- Correia MI, "The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis", Clin Nutr, 22, pp.235~239 (2003)
- Martin L, "Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index", J Clin Oncol, 31, pp.1539~1547 (2013)
- Fearon K, "Definition and classification of cancer cachexia: an international consensus", Lancet Oncol, 12, pp.489~495 (2011)
- Brookes GB, "Nutritional status: a prognostic indicator in head and neck cancer", Otolaryngol Head Neck Surg, 93, pp.69~74 (1985)
- Mitrache C, "Anemia : an indicator for malnutrition in the elderly", Ann Hematol, 80, pp.295~298 (2001)
- Bailey KV, "Use of body mass index of adults in assessing individual and community nutritional status", Bull World Health Organ, 73, pp.673~680 (1995)
- Onodera T, "Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients", Nihon Geka Gakkai Zasshi, 85, pp.1001~1005 (1984)
- Szkandera J, "Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients", PLoS One, 9, pp.e107297~ (2014)
- Nozoe T, "Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma", Surg Today, 40, pp.440~443 (2010)
- Kalantar-Zadeh K, "Risk factor paradox in wasting diseases", Curr Opin Clin Nutr Metab Care, 10, pp.433~442 (2007)
- Gridelli C, "Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel", Ann Oncol, 15, pp.419~426 (2004)
- Yang JC, "Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin", pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations, 2013, pp.31, 3342~3350
- Arora A, "Role of tyrosine kinase inhibitors in cancer therapy", J Pharmacol Exp Ther, 315, pp.971~979 (2005)
- Reck M, "Metastatic nonsmall-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 25(Suppl 3), pp.iii27~iii39 (2014)
- Fearon K, "Understanding the mechanisms and treatment options in cancer cachexia", Nat Rev Clin Oncol, 10, pp.90~99 (2013)
- Simons JP, "Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial", Cancer, 82, pp.553~560 (1998)
- Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5, pp.649~655 (1982)
- Finkelstein DM, "Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study", J Clin Oncol, 4, pp.702~709 (1986)
- Cessot A, "Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer", Nutr Cancer, 65, pp.1254~1257 (2013)
- Capuano G, "Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment", Support Care Cancer, 18, pp.433~437 (2010)
- Ravasco P, "Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy", J Clin Oncol, 23, pp.1431~1438 (2005)
- Baldwin C, "Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis", J Natl Cancer Inst, 104, pp.371~385 (2012)
- Berclaz G, "Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience", Ann Oncol, 15, pp.875~884 (2004)
- Dawood S, "Prognostic value of body mass index in locally advanced breast cancer", Clin Cancer Res, 14, pp.1718~1725 (2008)
- Key TJ, "Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women", J Natl Cancer Inst, 95, pp.1218~1226 (2003)
- Halabi S, "Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer", J Clin Oncol, 23, pp.2434~2435 (2005)
- Fearon KC, "Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis", Am J Clin Nutr, 83, pp.1345~1350 (2006)